Intravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel Surgery
Status:
Withdrawn
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
Currently, there are no studies that address the optimum dosage of lidocaine for surgical
procedures. Lidocaine is a local anesthetic that is injected to induce anesthesia. Improper
or inefficient pain treatment can lead to longer hospital stay, and adverse side effects such
as nausea and vomiting. Opioids are the primary drug to treat moderate to severe pain, but
are also responsible for nausea and other side effects. Lidocaine has shown to have opioid
sparing effects; meaning less opioid use is necessary for pain relief. In this study, we will
conduct a clinical trial to assess the difference between different lidocaine dosage
schedules to determine the optimum dosage that brings maximum pain relief while minimizing
adverse side effects and patient stay. A large benefit in using lidocaine is its documented
opioid sparing which allows for minimal drug treatment.